NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on: December 20,2023

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on:December 20,2023

Scientists develop new targeted therapeutic strategies to fight liver metastasis

by Qiu Rong, University of Science and Technology of ChinaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI157937The research group led by Prof. Zeng Zhu

Updated on: December 27,2023

Scientists develop new targeted therapeutic strategies to fight liver metastasis

by Qiu Rong, University of Science and Technology of ChinaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI157937The research group led by Prof. Zeng Zhu

Updated on:December 27,2023

Scientists pinpoint protein that helps cancer-causing viruses evade immune response

by Mark Derewicz,University of North Carolina School of MedicineViruses (EBV and KSHV) surrounding cells. Credit: Damania LabThe viruses Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-

Updated on: December 27,2023

Scientists pinpoint protein that helps cancer-causing viruses evade immune response

by Mark Derewicz,University of North Carolina School of MedicineViruses (EBV and KSHV) surrounding cells. Credit: Damania LabThe viruses Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-

Updated on:December 27,2023

Graphene Brain Chip Pioneers Cancer Cell Localization

Updated on: November 07,2024

Graphene Brain Chip Pioneers Cancer Cell Localization

Updated on:November 07,2024

Normalizing tumor blood vessels may improve immunotherapy against brain cancer

by Noah Brown,Massachusetts General HospitalAnti-VEGF treatment improves the efficacy of EGFRvIII-CAR-T cells in murine GBM tumor models. (A) Schematic representation of experimental setup to ev

Updated on: January 04,2024

Normalizing tumor blood vessels may improve immunotherapy against brain cancer

by Noah Brown,Massachusetts General HospitalAnti-VEGF treatment improves the efficacy of EGFRvIII-CAR-T cells in murine GBM tumor models. (A) Schematic representation of experimental setup to ev

Updated on:January 04,2024

Scientists unlock potential for a small cell lung cancer blood test

by Mike Addelman,University of ManchesterMethylation score predicts survival in patients with SCLC. a, Kaplan–Meier curves showing OS of the 78 patients with SCLC stratified by high and low meth

Updated on: December 27,2023

Scientists unlock potential for a small cell lung cancer blood test

by Mike Addelman,University of ManchesterMethylation score predicts survival in patients with SCLC. a, Kaplan–Meier curves showing OS of the 78 patients with SCLC stratified by high and low meth

Updated on:December 27,2023

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on: December 26,2023

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on:December 26,2023

Lack of self-exams hampers early melanoma identification

(HealthDay)—The biggest obstacle to early detection and treatment of melanoma among residents of rural, frontier communities is a chronic lack of skin self-examination (SSE), according to a study rece

Updated on: December 22,2023

Lack of self-exams hampers early melanoma identification

(HealthDay)—The biggest obstacle to early detection and treatment of melanoma among residents of rural, frontier communities is a chronic lack of skin self-examination (SSE), according to a study rece

Updated on:December 22,2023

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on: December 22,2023

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on:December 22,2023

Novel genetic signature that can predict some kinds of breast cancer is identified

by Maria Fernanda Ziegler,FAPESPBlood vessels from the retina of a mouse with retinopathy, normal and pathological vessels stained green and red respectively. Credit: Ricardo GiordanoResearchers

Updated on: December 22,2023

Novel genetic signature that can predict some kinds of breast cancer is identified

by Maria Fernanda Ziegler,FAPESPBlood vessels from the retina of a mouse with retinopathy, normal and pathological vessels stained green and red respectively. Credit: Ricardo GiordanoResearchers

Updated on:December 22,2023

Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect

Updated on: March 20,2024

Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect

Updated on:March 20,2024

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on: January 11,2024

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on:January 11,2024